Factory Supply High Quality Mexidol Raw Powder CAS. 127464-43-1 99% Purity

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: mexidol
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• CAS: 127464-43-1
• Grade Standard: Medicine Grade
• Mf: C8h11no.C4h6o4
• MW: 255.268
• Transport Package: Bottle, Can, Drum, Plastic Container, Vacuum Packe
• Specification: Powder
• Trademark: Senwayer
• Origin: Wuhan, China
• HS Code: 3001200010
• Production Capacity: 1000kilograms Per Month

Product Description

Factory Supply High Quality mexidol  Raw Powder CAS.127464-43-1  99% Purity

Product name	mexidol
CAS no.	127464-43-1
Molecular Formula	C8H11NO.C4H6O4
Molecular Weight	255.268
Brand Name	Senwayer

What is Mexidol?

Emoxypine (2-ethyl-6-methyl-3-hydroxypyridine), also known as Mexidol or Mexifin when used as the succinate salt, it is a high-end antioxidant and antihypoxic drug with an unique multipurpose action mechanism. As a basis of antioxidant neuroprotection, Mexidol positively influences the main components of pathogenesis of a disease, connected with the processes of free-radicals oxidation and oxygen-dependent pathological conditions. 

Mexidol chemical structure resembles that of pyridoxine (a type of vitamin B6).It is an axiolytic nootropic with anticonvulsant, neuroprotective and anti-inflammatory actions. It improves cerebral bloodflow, lowers cholesterol and is cardioprotective. It also increases dopamine levels in the brain. 

 

1. Mexidol found a successful use in neurology, therapeutics, psychiatry, surgery and addictology.

2. Emoxypine succinate offers anti-depressive, dermaprotective, and stress reducing. 

3. Emoxypine improves the cognitive function and brain health of patients with mental damage and disorders by increasing mitochondrial oxygen consumption.

4. Emoxypine increases the average blood flow in patients with heart trouble, while also reducing oxidative stress.

5. Emoxypine helps improve vision by way of increasing blood flow to the retinal artery.